Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for DOD Biotech PCL's Price-to-Tangible-Book or its related term are showing as below:
BKK:DOD-R'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.49 Med: 2.03 Max: 4.83
Current: 0.5
During the past 12 years, DOD Biotech PCL's highest Price to Tangible Book Ratio was 4.83. The lowest was 0.49. And the median was 2.03.
BKK:DOD-R's Price-to-Tangible-Book is ranked better than 89.96% of 1812
companies
in the Consumer Packaged Goods industry
Industry Median: 1.565
vs BKK:DOD-R: 0.50
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
DOD Biotech PCL Price-to-Tangible-Book Related Terms
DOD Biotech PCL Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:DOD-R vs KHC, GIS: Price-to-Tangible-Book Comparison
For the Packaged Foods subindustry, DOD Biotech PCL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DOD Biotech PCL Price-to-Tangible-Book vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where DOD Biotech PCL's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
DOD Biotech PCL (BKK:DOD-R) has a Price-to-Tangible-Book of 0.49 as of Sep. 05, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on DOD Biotech PCL and its competitors. According to the industry distribution chart, DOD Biotech PCL ranks #182 out of 1812 companies in the Consumer Packaged Goods industry, placing it in the top 10%.
Is DOD Biotech PCL's Price-to-Tangible-Book too high?
DOD Biotech PCL's current Price-to-Tangible-Book is 0.49. The Consumer Packaged Goods industry median Price-to-Tangible-Book is 1.57. DOD Biotech PCL's value of 0.49 is 68.7% below this industry median. Based on the distribution chart, DOD Biotech PCL ranks #182 out of 1812 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, DOD Biotech PCL has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Price-to-Tangible-Book compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, DOD Biotech PCL ranks #182 out of 1812 companies for Price-to-Tangible-Book. This places DOD Biotech PCL in the top 10% of its industry — outperforming the majority of peers. The industry median Price-to-Tangible-Book is 1.57. DOD Biotech PCL's value of 0.49 is 68.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Consumer Packaged Goods company?
The median Price-to-Tangible-Book among Consumer Packaged Goods companies is 1.57, based on 1,812 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DOD Biotech PCL's current Price-to-Tangible-Book of 0.49 is 68.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on DOD Biotech PCL and its competitors. For the Consumer Packaged Goods industry, the median Price-to-Tangible-Book is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DOD Biotech PCL's current Price-to-Tangible-Book is 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
DOD Biotech PCL (BKK:DOD-R) has a current Price-to-Tangible-Book of 0.49. The stock's GF Value™ is ฿1.52, compared to a current price of ฿0.97 — trading 36.4% below its estimated fair value. The current Price-to-Tangible-Book is 0.49 and 68.7% below the Consumer Packaged Goods industry median of 1.57. DOD Biotech PCL's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD-R), the current Price-to-Tangible-Book is 0.49 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD-R) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿0.97 is trading 36.4% below its estimated GF Value™ of ฿1.52.
Key valuation signals for BKK:DOD-R:
Price-to-Tangible-Book: 0.49
GF Value™: ฿1.52 vs. price of ฿0.97 (36.4% below fair value)
Industry Position: 68.7% below the Consumer Packaged Goods median (#182 of 1812)
No single metric tells the full story. See the BKK:DOD-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
67GF Score
Get the complete analysis for BKK:DOD-R
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD-R has been successfully added to your 
